BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21189980)

  • 1. A case of Bartter syndrome type I with atypical presentations.
    Lee EH; Heo JS; Lee HK; Han KH; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2010 Aug; 53(8):809-13. PubMed ID: 21189980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bartter Syndrome Type 1 Presenting as Nephrogenic Diabetes Insipidus.
    Vergine G; Fabbri E; Pedini A; Tedeschi S; Borsa N
    Case Rep Pediatr; 2018; 2018():9175271. PubMed ID: 29527380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous CLCNKB variant: An early presentation of classic Bartter syndrome in a neonate.
    Yaprak D; Kara H; Calisici E; Karagöl BS; Altan M
    Birth Defects Res; 2023 Oct; 115(17):1674-1679. PubMed ID: 37587715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal Bartter Syndrome Caused by a Novel Homozygous Mutation in
    Acar FA; Işik G; Mutlu M; Kader Ş; Aslan Y; Kalyoncu M
    Indian J Nephrol; 2019; 29(5):360-363. PubMed ID: 31571745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy.
    Nozu K; Yamamura T; Horinouchi T; Nagano C; Sakakibara N; Ishikura K; Hamada R; Morisada N; Iijima K
    Pediatr Int; 2020 Apr; 62(4):428-437. PubMed ID: 31830341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review.
    Jiang L; Li D; Guo Q; Li Y; Zan L; Ao R
    Endocr J; 2024 May; 71(5):537-542. PubMed ID: 38508775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation of
    Cho HW; Lee ST; Cho H; Cheong HI
    Korean J Pediatr; 2016 Nov; 59(Suppl 1):S103-S106. PubMed ID: 28018459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in
    Tian M; Peng H; Bi X; Wang YQ; Zhang YZ; Wu Y; Zhang BR
    Front Med (Lausanne); 2022; 9():862514. PubMed ID: 35463019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients.
    Wongsaengsak S; Vidmar AP; Addala A; Kamil ES; Sequeira P; Fass B; Pitukcheewanont P
    Bone; 2017 Apr; 97():121-125. PubMed ID: 28095294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses.
    Yi S; Li M; Yang Q; Zhang X; Chen F; Qin Z; Yi S; Huang L; Wei H; Zhang Q; Luo J
    Clin Chim Acta; 2022 Jun; 531():120-125. PubMed ID: 35358470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis.
    Yamazaki H; Nozu K; Narita I; Nagata M; Nozu Y; Fu XJ; Matsuo M; Iijima K; Gejyo F
    Pediatr Nephrol; 2009 Feb; 24(2):415-8. PubMed ID: 18830715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis of Bartter syndrome in Korea.
    Lee BH; Cho HY; Lee H; Han KH; Kang HG; Ha IS; Lee JH; Park YS; Shin JI; Lee DY; Kim SY; Choi Y; Cheong HI
    Nephrol Dial Transplant; 2012 Apr; 27(4):1516-21. PubMed ID: 21865213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1.
    Adachi M; Asakura Y; Sato Y; Tajima T; Nakajima T; Yamamoto T; Fujieda K
    Endocr J; 2007 Dec; 54(6):1003-7. PubMed ID: 17998760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes.
    Bamgbola OF; Ahmed Y
    Clin Kidney J; 2021 Jan; 14(1):36-48. PubMed ID: 33564404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis.
    Lee SE; Han KH; Jung YH; Lee HK; Kang HG; Moon KC; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2011 Jan; 54(1):36-9. PubMed ID: 21359059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic variability in Bartter syndrome type I.
    Bettinelli A; Ciarmatori S; Cesareo L; Tedeschi S; Ruffa G; Appiani AC; Rosini A; Grumieri G; Mercuri B; Sacco M; Leozappa G; Binda S; Cecconi M; Navone C; Curcio C; Syren ML; Casari G
    Pediatr Nephrol; 2000 Sep; 14(10-11):940-5. PubMed ID: 10975303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic characteristics of children with Bartter syndrome.
    Güven S; Gökçe İ; Alavanda C; Çiçek N; Demirci EB; Sak M; Pul S; Türkkan ÖN; Yıldız N; Ata P; Alpay H
    Turk J Pediatr; 2022; 64(5):825-838. PubMed ID: 36305432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome.
    Finer G; Shalev H; Birk OS; Galron D; Jeck N; Sinai-Treiman L; Landau D
    J Pediatr; 2003 Mar; 142(3):318-23. PubMed ID: 12640382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of Bartter syndrome in 54 patients: A multicenter study in Korea.
    Choi N; Kim SH; Bae EH; Yang EM; Lee KH; Lee SH; Lee JH; Ahn YH; Cheong HI; Kang HG; Hyun HS; Kim JH
    Front Med (Lausanne); 2023; 10():1099840. PubMed ID: 36993809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of next generation sequencing in the correct diagnosis of congenital hypochloremic hypokalemic metabolic alkalosis.
    Ben-David Y; Halevy R; Sakran W; Zehavi Y; Spiegel R
    Eur J Med Genet; 2019 Oct; 62(10):103728. PubMed ID: 31325522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.